42 Emerging Medical Technology Companies Seeking Funding and/or Strategic Partnership Confirmed to Date to Present at Medtech Insight's 'In3 WEST' Investment and Partnering Conference, Feb. 23-24, Irvine, Calif.NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif. -- Medtech Insight and Windhover wind·hov·er n. Chiefly British A kestrel. Information have announced that 42 early-stage medical technology companies from seven different countries are confirmed to present thus far at their upcoming "Investment In Innovation (In3) WEST: A Preview of Early-Stage Medical Technology Companies" conference, being held Feb. 23-24, 2006, at the Hyatt Regency Irvine in Irvine, Calif. A total of 50 innovative young medical device companies developing products for a variety of high-growth medical technology markets -- including cardiovascular/peripheral vascular, orthopedics/spine, imaging, neuro/stroke, wound management, diagnostics, biomaterials, tissue engineering, diabetes, drug delivery, oncology, and ophthalmology, among others -- will present to an audience of the top dealmakers in the medical technology and investment communities, for purposes of funding and/or strategic partnership. Presenting companies confirmed thus far include (most presenting at a Medtech Insight event for the first time; more being added regularly): ACell, AcuNetx, Advanced Cell Technology, Advanced Imaging Systems, AerovectRx, AION AION Anterior Ischemic Optic Neuropathy Diagnostics, BioImagene, Biosan Medical, BioTHER, Brain Matters, Cardiovascular Systems, Cavitech, CleveX, Crosscart, CVAC CVAC Carolina-Virginia Athletic Conference CVAC Cyclic Variations in Altitude Conditioning CVAC Chappaqua Volunteer Ambulance Corps (Chappaqua, New York) CVAC Consolidated Vultee Aircraft Corporation Systems, Cytograft Tissue Engineering, Design Medical, Dialog Devices, Duke Vascular, EndoCor, Gluco Stats System, HemoBioTech, InfraScan, InnerVision Medical Technologies, IYIA Technologies, Lingualcare, LiverCyte, MedicalCV, Minnow minnow, common name for the Cyprinidae, a large family of freshwater fish which includes the carp (Cyprinus carpio), and of which there are some 300 American species. The European minnow is Phoxinus phoxinus. Medical, OtisMed, Paieon, Paradigm Spine, Pathfinder Therapeutics, PhotoImmune Biotechnology, Power Paper, SpinX Technologies, SurgiFile, Symphony Medical, TEKIA, Urovalve, VasoGenix Pharmaceuticals, and Vision Solutions Technologies, among others. See the Medtech Insight Web site for full event details: http://www.medtechinsight.com/in3-16.html. In3 WEST will also feature tabletop exhibits and product prototypes by presenting companies during a networking dinner, and a keynote presentation by Michael Henson Michael Henson is a Cincinnati based teacher, activist and writer. Born April 14, 1947 in Sidney, Ohio he moved to Cincinnati to attend Xavier University where he majored in English. He later received a masters in English from University of Chicago. , general partner at MedFocus Fund and founder/CEO/chairman/board member of 16 emerging healthcare companies titled "From Invention to Commercialization ... and Beyond." Scott Wolf, M.D., partner at Prospect Venture Partners and founder of Percardia, Cardiac Dimensions, Archus Orthopedics and Endogastric Solutions, will give the "State of Medtech Investing - 2006" presentation. The event will also feature an interactive panel discussion titled "The Big Company Perspective on Deal-Making," on Friday, Feb. 24. The high-powered panel will explore the medical device deal-making phenomenon from a number of angles, including examining what the appetite for big companies will be in the coming years; how much will deal-making remain within a company's historic technology/clinical spaces, and how much will they use it to extend beyond; how have deal-making strategies, approaches, and structures changed over the past several years; what criteria do big companies use in identifying and targeting small companies; and how have the strong IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard. market and other factors affected valuations. Prominent device industry panelists include Matt Alves, VP, strategic development, at Stryker Insruments, and Stuart Foster, corporate VP, technology & discovery at Edwards Lifesciences, among others to be announced To be announced (TBA) A contract for the purchase or sale of an MBS to be delivered at an agreed-upon future date but does not include a specified pool number and number of pools or precise amount to be delivered. soon. The panel will be moderated by David Cassak, managing partner at Windhover Information. The In3 WEST audience will include top decision makers from these medical technology companies and investment firms, among many others with a specific interest in early-stage medical technology companies: 3i, Abbott Laboratories, Aberdare Ventures, Aubrey Group, Baird Venture Partners, BD Medical, Boston Scientific, C.R. Bard, COBE COBE: see infrared astronomy. Cardiovascular, Cordis, Datascope, De Novo [Latin, Anew.] A second time; afresh. A trial or a hearing that is ordered by an appellate court that has reviewed the record of a hearing in a lower court and sent the matter back to the original court for a new trial, as if it had not been previously heard nor decided. Ventures, DuPont BioSciences, Edwards Lifesciences, Ethicon, Ethicon Endo-Surgery, Guidant, Johnson & Johnson, KeyBanc Capital Markets, Kimberly-Clark, Medtronic, Merck, Musculoskeletal musculoskeletal /mus·cu·lo·skel·e·tal/ (-skel´e-t'l) pertaining to or comprising the skeleton and muscles. mus·cu·lo·skel·e·tal adj. Relating to or involving the muscles and the skeleton. Transplant Foundation, Olympus America, Prospect Venture Partners, Regeneration Technologies, Smith & Nephew, St. Jude Medical St. Jude Medical, Inc. NYSE: STJ is a $2.9 billion global cardiovascular device company, with headquarters in St. Paul, Minnesota, United States. The company sells products in more than 100 countries and has over 20 operations and manufacturing facilities worldwide. , Stryker, Thomas Weisel Healthcare Venture Partners, Triathlon Medical Ventures, Tyco Healthcare, US Army Medical Research & Material Command, U.S. Surgical, Versant Ventures, and Wilson Sonsini Goodrich & Rosati, among many others being confirmed regularly. In3 WEST co-sponsors include AdvaMed, Battelle, Business Wire, Medmarc and The Hartford, Ronald Trahan Associates, Rutan & Tucker LLP LLP - Lower Layer Protocol , Teledyne Medical Microsystems, The MedTech Group, and Underwriters Laboratories. To register to attend IN3 WEST or if your emerging company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., e-mail kristy@medtechinsight.com, or visit www.medtechinsight.com. About Medtech Insight Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, and to see the company's 2006 conference schedule, please visit www.medtechinsight.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion